No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
SAVA Cassava Sciences
- 12.830
- +2.750+27.28%
Close Jul 22 16:00 ET
- 12.845
- +0.015+0.11%
Pre 09:19 ET
615.53MMarket Cap-5912P/E (TTM)
13.788High10.420Low10.72MVolume10.430Open10.080Pre Close135.93MTurnover23.82%Turnover RatioLossP/E (Static)47.98MShares32.10052wk High7.83P/B577.13MFloat Cap8.79052wk Low--Dividend TTM44.98MShs Float146.160Historical High--Div YieldTTM33.41%Amplitude1.000Historical Low12.685Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Cassava Shares Rise After Incoming Chairman Gives Timeline for Alzheimer's Drug Study Read Out
Cassava Sciences Advances Alzheimer's Drug Through High-Stakes Phase 3 Trials
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday
Why Cassava Sciences Stock Is Skyrocketing Today
Express News | Cassava Sciences Shares Are Trading Higher After the Company Announced Its First Phase 3 Trial Is Expected to Conclude by December and Its Second Phase 3 Trial Is Expected to Conclude by June 2025
Comments
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
